Second Sight Medical (EYES) Tops Q4 EPS by 1c

Second Sight Medical (NASDAQ: EYES) reported Q4 EPS of ($0.10), $0.01 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $1.8 million versus the consensus estimate of $2.64 million.

For earnings history and earnings-related data on Second Sight Medical (EYES) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
• Reading (RDI) Tops Q2 EPS by 4c